Using Cannabis to Treat Cancer-Related Pain

被引：10
作者：
Byars, Timothy [1 ]
Theisen, Eloise [1 ]
Bolton, Deborah L. [2 ]
机构：
[1] Radicle Hlth, 2815 Mitchell Dr,Suite 119, Walnut Creek, CA 94598 USA
[2] Deborah Bolton Consulting, Los Gatos, CA USA
来源：
SEMINARS IN ONCOLOGY NURSING | 2019年 / 35卷 / 03期
关键词：
Cannabis; Cancer; Pain; Endocannabinoid; Nursing; Marijuana; NEUROPATHIC PAIN; PLANT; RECEPTORS; CB1; ENDOCANNABINOIDS; ANANDAMIDE; MANAGEMENT; ANALGESIA; EFFICACY; AGONIST;
D O I：
10.1016/j.soncn.2019.04.012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Objective: To describe which cannabinoids and terpenes are effective for treating pain. Data Sources: Peer-reviewed articles, book chapters. Conclusion: Cannabis and cannabinoid medicines, as modulators of the endocannabinoid system, offer novel therapeutic options for the treatment of cancer-related pain, not only for patients who do not respond to conventional therapies, but also for patients who prefer to try cannabis as a first treatment option. Implications for Nursing Practice: Understanding the endocannabinoid system, cannabinoids, terpenes, routes of administration, potential drug interactions, clinical implications, and potential side effects ensures nurses can better assist patients who use cannabis for the treatment of cancer pain. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码：300 / 309
页数：10
相关论文
共 96 条
  • [1] A2LA, 2019, CANN TEST LAB ACCR P
  • [2] Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors
    Agarwal, Nitin
    Pacher, Pal
    Tegeder, Irmgard
    Amaya, Fumimasa
    Constantin, Cristina E.
    Brenner, Gary J.
    Rubino, Tiziana
    Michalski, Christoph W.
    Marsicano, Giovanni
    Monory, Krisztina
    Mackie, Ken
    Marian, Claudiu
    Batkai, Sandor
    Parolaro, Daniela
    Fischer, Michael J.
    Reeh, Peter
    Kunos, George
    Kress, Michaela
    Lutz, Beat
    Woolf, Clifford J.
    Kuner, Rohini
    [J]. NATURE NEUROSCIENCE, 2007, 10 (07) : 870 - 879
  • [3] [Anonymous], 2017, HLTH EFF CANN CANN C
  • [4] Cannabis Epidemiology: A Selective Review
    Anthony, James C.
    Lopez-Quintero, Catalina
    Alshaarawy, Omayma
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (42) : 6340 - 6352
  • [5] Are oral cannabinoids safe and effective in refractory neuropathic pain?
    Attal, N
    Brasseur, L
    Guirimand, D
    Clermond-Griamien, S
    Atlami, S
    Bouhassira, D
    [J]. EUROPEAN JOURNAL OF PAIN, 2004, 8 (02) : 173 - 177
  • [6] Australian Government Department of Health Therapeutic Goods Administration, 2013, AUSTR PUBL ASS REP N
  • [7] Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010
    Bachhuber, Marcus A.
    Saloner, Brendan
    Cunningham, Chinazo O.
    Barry, Colleen L.
    [J]. JAMA INTERNAL MEDICINE, 2014, 174 (10) : 1668 - 1673
  • [8] Effect of Δ9-tetrahydrocannabinol, a cannabinoid receptor agonist, on the triggering of transient lower oesophageal sphincter relaxations in dogs and humans
    Beaumont, H.
    Jensen, J.
    Carlsson, A.
    Ruth, M.
    Lehmann, A.
    Boeckxstaens, G. E.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2009, 156 (01) : 153 - 162
  • [9] Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial
    Berman, JS
    Symonds, C
    Birch, R
    [J]. PAIN, 2004, 112 (03) : 299 - 306
  • [10] Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis
    Blake, DR
    Robson, P
    Ho, M
    Jubb, RW
    McCabe, CS
    [J]. RHEUMATOLOGY, 2006, 45 (01) : 50 - 52
12345678910